Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / APRE - Aprea Therapeutics regains Nasdaq compliance with minimum bid price requirement

APRE - Aprea Therapeutics regains Nasdaq compliance with minimum bid price requirement

Aprea Therapeutics Inc.
  • Aprea Therapeutics ( NASDAQ: APRE ) received formal notice from The Nasdaq Stock Market that it has regained compliance with its minimum bid price for continued listing on the Nasdaq Global Select Market.
  • "We are excited about regaining compliance and we believe our recent financing, which was supported by quality institutions, has strengthened our balance sheet and enabled the Company to continue developing its clinical asset, ATRN-119, and its pre-clinical asset ATRN-W1051," President & CEO Oren Gilad, Ph.D. commented.

For further details see:

Aprea Therapeutics regains Nasdaq compliance with minimum bid price requirement
Stock Information
Company Name: Aprea Therapeutics Inc.
Stock Symbol: APRE
Market: NASDAQ
Website: aprea.com
Menu
APRE APRE Quote APRE Short APRE News APRE Articles APRE Message Board
Get APRE Alerts

News, Short Squeeze, Breakout and More Instantly...